stem cell technologies current state future promise l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Stem cell technologies Current state Future promise PowerPoint Presentation
Download Presentation
Stem cell technologies Current state Future promise

Loading in 2 Seconds...

play fullscreen
1 / 22

Stem cell technologies Current state Future promise - PowerPoint PPT Presentation


  • 383 Views
  • Uploaded on

Stem cell technologies Current state Future promise Where UCI fits in to the Post Prop. 71 world of biotechnology development in California Proposition 71: Purpose and Intent Create California Institute for Regenerative Medicine. Oversight by Independent Citizen’s Oversight Committee (ICOC).

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Stem cell technologies Current state Future promise' - salena


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
stem cell technologies current state future promise

Stem cell technologiesCurrent stateFuture promise

Where UCI fits in to the Post Prop. 71 world of biotechnology development in California

proposition 71 purpose and intent
Proposition 71: Purpose and Intent
  • Create California Institute for Regenerative Medicine.
      • Oversight by Independent Citizen’s Oversight Committee (ICOC).
  • Support the development of technologies involving pluripotent stem cell and progenitor cell.
      • Prohibit human reproductive cloning
proposition 71 funds
Proposition 71: Funds
  • Funding details
      • Authorizes an average of $295 million per year in bonds over a 10-year period, $3 billion total
      • In any year, no more than $350 million in bonds to be issued
        • If less than $350 million is issued in any year, the remaining permitted amount may be carried over to one or more subsequent years
proposition 71 research facilities
Proposition 71: Research facilities
  • Research facilities that can be used for research on “non-approved lines” are a priority.
  • Accordingly, up to 10% of the funds will be used to build scientific and medical research facilities of nonprofit entities.
  • These are to be constructed in the first five years, with priority given to facilities that can be brought on line within the first 2 years.
  • Funding through Prop. 71 for development of facilities requires a 20% match.
proposition 71 oversight
Proposition 71: Oversight

The ICOC must meet in an open meeting format.

Closed sessions may be conducted when discussing:

  • Matters involving information relating to patients or medical subjects. Matters involving confidential intellectual property or work product
  • Matters involving prepublication, confidential scientific research or data
  • Matters concerning the appointment, employment, performance, compensation, or dismissal of institute officers and employees
proposition 71 scientific and medical working groups
Proposition 71: Scientific and Medical Working Groups
  • Scientific and Medical Research Funding Working Group.
  • Scientific and Medical Accountability Standards Working Group.
  • Scientific and Medical Research Facilities Working Group.
slide7

R

R

C

A primer on Human Embryonic Stem Cells

Blastocyst -

from In Vitro Fertilization Clinic

“Blueprint” cells

Inner Cell Mass

(Stem Cells)

A Blastocyst is a hollow ball of cells with a small clump of stem cells inside

slide8

Blastocyst -

from In Vitro Fertilization Clinic

Stem Cells

“Blueprint” cells

A Blastocyst is a hollow ball of cells with a small clump of stem cells inside

Human Embryonic Stem Cells

Pipette

“Blueprint”

cells

Stem Cells

To remove the stem cells, the Blastocyst is opened and the stem cells removed with a pipette

slide9

Blastocyst -

from In Vitro Fertilization Clinic

Stem Cells

“Blueprint” cells

A Blastocyst is a hollow ball of cells with a small clump of stem cells inside

Human Embryonic Stem Cells

Pipette

“Blueprint”

cells

Stem Cells

Stem Cells

To remove the stem cells, the Blastocyst is broken open and the stem cells removed with a pipette(an ultra thin glass tube)

The stem cells are placed in a

dish and are fed and cared for

(each blastocyst =

1 stem cell line)

Pipette

Petri Dish

slide10

Growth factors

Chemical cues

Petri Dish

Stem Cells

Pancreatic

Islet

Muscle

cell

Neuron

Different chemicals / molecules are added to the stem cells to make them become specific types of cells.

slide12

Blastocyst

Stem Cells

Somatic Cell Nuclear Transfer or Therapeutic Cloning

Donor Egg

Skin Cell

Nucleus

(DNA)

Nucleus

(DNA)

Needle

Needle

Stem Cells

Chemicals and

Growth Factors

Pancreatic

Islet

Neuron

Muscle cell

Dividing cells

the vision for uci s stem cell center stem cell therapies for neurological disorders

Reeve-Irvine Research Center

The vision for UCI’s Stem Cell Center: Stem cell therapies for neurological disorders
  • Brain and spinal cord injury.
  • Stroke.
  • Neurodegenerative diseases
    • Parkinson’s Disease
    • Huntington’s Disease
    • Alzheimer’s Disease
    • Multiple Sclerosis
    • Lou Gerhig’s Disease (ALS)
neurological disorders involve the loss of particular cell types in the nervous system

Reeve-Irvine Research Center

Neurological disorders involve the loss of particular cell types in the nervous system
  • Brain and spinal cord injury and stroke (loss of nerve cells and myelin-forming oligodendrocytes).
  • Neurodegenerative diseases
    • Parkinson’s Disease (loss of dopamine-containing nerve cells in the brainstem).
    • Huntington’s Disease (loss of nerve cells in the striatum).
    • Alzheimer’s Disease (loss of nerve cells in the cerebral cortex).
    • Multiple Sclerosis (loss of myelin-forming oligodendrocytes).
    • Lou Gerhig’s Disease-ALS (loss of motor neurons from the spinal cord).
  • The vision: To use embryonic stem cells to restore the cells that are lost as a result of injury or neurodegenerative diseases.
slide15

Reeve-Irvine Research Center

Goal #1: to make stem cells into nerve cells

Stem Cells

Blastocyst -

Pipette

“Blueprint”

cells

Petri Dish

Stem Cells

“Blueprint” cells

Stem Cells

The stem cells are treated with factors to cause them to differentiate into particular cell types

Stem cells differentiated into neurons

slide16

Reeve-Irvine Research Center

Goal #2: To discover how to make stem cells integrate into neural circuits.

Oligodendrocyte

Nerve cell (neuron)

More research is needed to find the ways to actually use stem cells for therapeutic applications.

at the rirc a therapy is being developed to use stem cells to replace myelin forming cells

Reeve-Irvine Research Center

At the RIRC, a therapy is being developed to use stem cells to replace myelin-forming cells

Myelin-forming cells (oligodendrocytes) die as a result of spinal cord injury, resulting in the loss of myelin (insulation) from nerve fibers.

An important potential therapeutic strategy: Replace myelin-forming cells using stem cells that differentiate into oligodendrocytes.

slide18

Keirstead Lab

Reeve-Irvine Research Center

RIRC scientists have succeeded in developing ways to produce oligodendrocytes from human ES cells and have shown that they can restore myelin after spinal cord injury in experimental animals.

Stem cells are first differentiated to the neural lineage.

Then to Oligodendrocyte Precursors

slide20

Embryonic Stem Cells

They can generate large quantities of tissue rapidly

Human Embryonic Stem Cells

2. They can become any cell in the body

Embryonic stem cells

Brain

Heart

Fat

Bone marrow

Cartilage

developing facilities for stem cell research

Reeve-Irvine Research Center

Developing facilities for stem cell research
  • It is likely that research involving non-approved stem cell lines will be prohibited in facilities that were built with NIH support, or that contain NIH-supported core equipment.
  • In recognition of this, up to 10% of Prop. 71 funds will be used to build scientific and medical research facilities.
  • Funding through Prop. 71 for development of facilities requires a 20% match.
proposition 71 funds22
Proposition 71: Funds
  • Indirect costs limited to 25 % of a research award
    • Excluding amounts included in a facilities award
    • Indirect cost limitation may be increased by amount the grantee provides in matching funds
      • Must be in excess of 20% of the grant amount